FDA Drug Recalls

Recalls / Class II

Class IID-1251-2015

Product

Lansoprazole Delayed-Release Capsules, USP, 15 mg Capsules, For Repackaging Only, Packaged in 4500 Count Pouches, Over the Counter. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-140-00.

Affected lot / code info
Lot #: LN11086, Expiry: 5/31/2015.

Why it was recalled

CGMP Deviations: Firm did not adequately investigate customer complaints.

Recalling firm

Firm
Wockhardt Usa Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
20 Waterview Blvd Ste 3, N/A, Parsippany, New Jersey 07054-1271

Distribution

Quantity
848 Pouches
Distribution pattern
U.S. Nationwide including Puerto Rico.

Timeline

Recall initiated
2015-04-22
FDA classified
2015-07-17
Posted by FDA
2015-07-29
Terminated
2018-05-09
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1251-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.